Delivery Order SPE2DB24D2205-SPE2DB25FEFYY
- Not listed
- This delivery order, valued at $1,148.21, awards Amerisourcebergen Drug Corp the supply of Procrit 40,000 units/ml vials under a firm fixed price contract with the Defense Logistics Agency (DLA). The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside contract represents a competitive award to the pharmaceutical distributor for a critical injectable...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- This contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,575.16 firm-fixed-price delivery order is for the supply of 10,000 units/ml vials of PROCRIT, a medication, with an ultimate completion date of April 22, 2024. The contract is not associated with a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00...
- The Defense Logistics Agency Troop Support Medical awarded a $7,318 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561419252 PROCRIT 10,000 UNITS/ML VIAL 2ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 6, 2023 through July 7, 2023. This delivery order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,542.20 fixed-price delivery order is for the procurement of 40,000 units of the drug Procrit with a strength of 40,000 units/mL. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,000 units of PROCRIT 4,000 units/mL vials. The $2,424.68 contract has a completion date of February 6, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,666.43 contract is for the delivery of 40,000 units/mL vials of the pharmaceutical product PROCRIT. The delivery order has a completion date of January 24, 2024 and was awarded on January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division,...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,784.99 delivery order is for the supply of 10,000 units/ml of the drug Procrit. This award does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 20,000 units of PROCRIT 20,000 units/mL vial medication. The $4,210.78 firm-fixed-price contract was awarded on April 29, 2024 by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract with...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,505.03. This is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and represents a non-competitive set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFYYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Procrit 40,000 units/ml vials, a pharmaceutical product used in treating anemia and related conditions. This firm fixed-price delivery order has a ceiling value of $4,092.76 and is scheduled for completion by August 8, 2025. The contract is not set-aside and represents a competitive award to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen fulfills pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 8/7/25 |